Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Jacqueline Schmerber"'
Autor:
Marianne Paesmans, Paul Mommen, Jacqueline Schmerber, M.C. Florin, Jean-Jacques Lafitte, Jean-Paul Sculier, Thierry Berghmans, J. Baumöhl, Constantinos Zacharias, George Koumakis, Vincent Ninane, Constantinos Alexopoulos, Jean Klastersky, Jacques Thiriaux
Publikováno v:
British Journal of Cancer
A phase III randomized trial was conducted in patients with metastatic NSCLC, to determine if, in association with mitomycin (6 mg m–2) and ifosfamide (3 g m–2), the combination of moderate dosages of cisplatin (60 mg m–2) and carboplatin (200
Autor:
M. Borges, M.C. Berchier, O Van Cutsem, Jean-Paul Sculier, Roger Sergysels, Jacqueline Schmerber, Gérard Bureau, Marianne Paesmans, J. Michel, Jean Klastersky, G Dabouis, J. Lecomte, Paul Mommen, Michel Richez, V. Giner
Publikováno v:
Lung Cancer. 16:21-33
Purpose: To identify pretreatment variables predicting response to platinum derivatives containing chemotherapy in patients with unresectable non-small cell lung cancer (NSCLC). Patients and methods: Eligible patients included in one of the 7 consecu
Publikováno v:
Respiratory Medicine. 89(7):477-485
The aim of the study was to evaluate the relationship between several lung function indices and perceived dyspnoea during bronchoconstriction. Acute changes in lung function were induced by inhaled histamine followed by terbutaline, in 12 asthmatics
Autor:
Jacques Thiriaux, Gérard Bureau, Jacqueline Schmerber, G Dabouis, Jean-Paul Sculier, M.C. Berchier, Jean Klastersky, Marianne Paesmans, O Van Cutsem, P. Libert, Roger Sergysels, Fernand Ries, Alain Tagnon, Paul Mommen
Publikováno v:
Lung Cancer. 11:373-384
The purpose of this study was to determine the activity of a 4-drug combination chemotherapy: cisplatin, mitomycin C, vindesine and 5-fluorouracil (5-FU) in patients with advanced non-small cell lung cancer (NSCLC). Chemotherapy consisted of the admi
Publikováno v:
European Respiratory Journal. 7:279-285
The purpose of this study, in patients with chronic obstructive pulmonary disease (COPD), was to examine the relationship of dyspnoea, rated on a visual analogue scale (VAS), to 1) tidal ventilatory variables measured on exercise and 2) pre-exercise
Autor:
André Coune, Dany Brohée, G Vandermoten, Jean-Paul Sculier, Roger Sergysels, Jacqueline Schmerber, Pol Ravez, Jacques Thiriaux, P. Libert, Jean Klastersky, Gérard Bureau, J. Michel
Publikováno v:
Lung Cancer. 6:110-118
Two consecutive trials were conducted, testing the CAVi (cyclophosphamide 1 g/m 2 ; doxorubicin (adriamycin) 45 mg/m 2 ; vincristine 1.4 mg/m 2 ; all i.v. on day 1; every 3 weeks) combination as salvage therapy for small cell lung cancer (SCLC) after
Autor:
Alain Tagnon, Jacques Thiriaux, G Dabouis, Roger Sergysels, O Van Cutsem, P. Libert, Paul Mommen, Gérard Bureau, Marianne Paesmans, M.C. Berchier, Jean-Paul Sculier, Fernand Ries, Jacqueline Schmerber, Jean Klastersky
Publikováno v:
Annals of Oncology. 5:641-643
Summary Purpose To determine in patients with advanced non-small cell lung cancer the activity of a 4-drug combination chemotherapy. Patients and methods Chemotherapy consisted of the administration of cisplatin (30 mg/m2 d 1–3 or 4), mitomycin C (
Publikováno v:
Thorax. 47(5)
BACKGROUND: A study was carried out to determine whether rating of dyspnoea by means of a visual analogue scale during a progressive exercise test is affected by the subject's awareness of the progressive nature of the protocol. METHODS: Nineteen pat
Autor:
O Van Cutsem, V. Giner, P Recloux, A. Paccagnella, Gérard Bureau, V. Richard, P. Opálka, Paul Mommen, M.C. Berchier, Jean-Paul Sculier, Marianne Paesmans, Jean Klastersky, Jacqueline Schmerber, J. Baumöhl
Publikováno v:
Lung Cancer. 8:356
Autor:
Jean Pierre Carpiaux, M. Blogie, Eugène Yourassowsky, Jacqueline Schmerber, Youri Glupczynski, Thierry Prigogine
Publikováno v:
Journal of Antimicrobial Chemotherapy. 21:131-136
A total of 43 hospitalized adult patients with acute exacerbations of chronic bronchitis or bronchiectasis due to Gram-negative bacteria were randomized to receive either enoxacin (400 mg bd) or amoxycillin (1,000 mg tid) for 7-12 days. Micro-organis